NEW YORK, Feb 15 – Incyte said Thursday it has signed a collaboration with Genicon Sciences, a privately-held San Diego company, to use Genicon’s protein detection methods to expand their diverse product line to include antibody arrays.
This story has been updated from a previous version. NEW YORK, Feb 15 – Genomic Solutions said Thursday it moved for summary judgment, asking the court to dismiss the lawsuit filed against it by PerkinElmer. “We have filed the summary judgment motion in order to ach
This story has been updated from a previous version. NEW YORK, Feb 14 – Compugen said Wednesday its fourth-quarter revenues tripled to $3.3 million, compared with $1.1 million a year ago, while revenues for 2000 incr
NEW YORK, Feb 14 - PerkinElmer, a stockholder in Genomic Solutions and holder of foreign distribution rights to some of Genomic Solutions' gene and protein analysis products, has sued Genomic Solutions and its directors in Delaware Chancery Court, seeking to
NEW YORK, Feb 14 - In two separate signs on Wednesday that gene regulation technology is beginning to gain momentum, Wyeth-Ayerst Laboratories announced it would license Valentis' gene regulation technology, and London-based Gendaq published a
NEW YORK, Feb 14 – Gemini Genomics said Wednesday it recorded revenues of $72,000 in fiscal third-quarter 2001, compared with zero revenues in the year earlier quarter, as the result of license fees stemming from the company’s osteoporosis diagnostic effort. Rese
NEW YORK, Feb 14 – SciMagix, a Redwood Shores, Calif.-based bioinformatics company, unveiled its ProteinMine software for analyzing 2-d electrophoresis gels Wednesday. The software is designed to search 2-d gels according to si
NEW YORK, Feb 14 – Incyte has licensed its databases and will provide custom genomic services to GenomicFX, a company that is developing genomic diagnostic tools for cattle and swine breeding and production, the companies said Wednesday.
NEW YORK, Feb 13 – Bioinformatics tool provider Pharmacopeia said Tuesday it had promoted Michael Stapleton to the position of chief operating officer for the company’s software division and Stephen Spearman to the position of chief operating offic
NEW YORK, Feb 13 – Variagenics has been issued a patent for its proprietary haplotyping methods for determining differences in DNA polymorphisms between maternal and paternal chromosomes, the company sai
NEW YORK, Feb 13 – China’s Beijing Genome Institute has filed to establish a bioinformatics company in San Mateo, Calif., in an effort to gain access to the growing US genomics market, Matthew Huang, co-director of BGI said Tuesday.
NEW YORK, Feb 13 – Orchid and AstraZeneca have formed a three-year multimillion dollar SNP genotyping collaboration to conduct joint studies to identify SNPs related to a variety of diseases, the companies s
NEW YORK, Feb 13 – Ariad Pharmaceuticals received a patent for a method to control gene expression in humans and other animals, the company said Tuesday. The technology uses small molecules to regulate the extent of gene activation.
NEW YORK, Feb 13 – Structural proteomics company GeneFormatics said Tuesday it had hired Daniel Chambers as its vice president of intellectual property, a move designed to protect the company’s patent position.
NEW YORK, Feb 12 – News that Celera had published its human genome sequencing paper in Science and made its data available on its website helped to bolster genomics stocks Monday morning. Shares of Celera jumped
NEW YORK, Feb 12 – News that Celera had published its human genome sequencing paper in Science and made its data available on its website helped to bolster genomics stocks Monday morning. Shares of Celera jumped 3.3, or 7.
NEW YORK, Feb 12 – Public researchers spent long hours and weekends preparing their genome sequencing paper for this week’s seminal issue of Nature . And when all was said and done, it was the mouse that took the heat. " We met on phone calls almos
NEW YORK, Feb 12 - Blackstone Technology Group said Monday that it has built a compute farm to support genomics-based research at Pfizer’s Discovery Technology Center in Cambridge, Mass. Financial terms of the deal were not disclosed. Blackstone, based i
NEW YORK, Feb 12 – Following a break of the news embargo on Sunday by The Observer of London, coverage of the human genome papers in many media outlets on Sunday and Monday offered widely disparate analyses of the papers’ significance. In
NEW YORK, Feb 12 - Blackstone Technology Group said Monday that it has built a compute farm to support genomics-based research at Pfizer’s Discovery Technology Center in Cambridge, Mass. Financial terms of the deal were not disclosed.